Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2018

May 09, 2018

SELL
$169.43 - $198.0 $2.47 Million - $2.89 Million
-14,577 Closed
0 $0
Q3 2017

Nov 08, 2017

BUY
$167.29 - $191.0 $2.44 Million - $2.78 Million
14,577
14,577 $2.72 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $149B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Aegon Asset Management Uk PLC Portfolio

Follow Aegon Asset Management Uk PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aegon Asset Management Uk PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aegon Asset Management Uk PLC with notifications on news.